Publication:
BRAF, KRAS and PIK3CA Mutation and Sensitivity to Trastuzumab in Breast Cancer Cell Line Model

Simple item page
dc.contributor.authorsDirican, Ebubekir
dc.date.accessioned2022-03-14T04:29:50Z
dc.date.accessioned2026-01-11T08:24:58Z
dc.date.available2022-03-14T04:29:50Z
dc.date.issued2020
dc.identifier.doi10.31557/APJCP.2020.21.1.1
dc.identifier.issn2476-762X
dc.identifier.pubmedPMID: 31983154 PMCID: PMC7294037
dc.identifier.urihttps://hdl.handle.net/11424/238859
dc.language.isoeng
dc.relation.ispartofAsian Pacific journal of cancer prevention: APJCP
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectFemale
dc.subjectHumans
dc.subjectBiomarkers
dc.subjectProto-Oncogene Proteins B-raf
dc.subjectMutation
dc.subjectCell Line, Tumor
dc.subjectBreast Neoplasms
dc.subjectMCF-7 Cells
dc.subjectbreast cancer
dc.subjectTrastuzumab
dc.subjectClass I Phosphatidylinositol 3-Kinases
dc.subjectProto-Oncogene Proteins p21(ras)
dc.subjectPIK3CA
dc.subjectCell line
dc.titleBRAF, KRAS and PIK3CA Mutation and Sensitivity to Trastuzumab in Breast Cancer Cell Line Model
dc.typearticle
dspace.entity.typePublication
oaire.citation.startPage1
oaire.citation.titleAsian Pacific journal of cancer prevention: APJCP
oaire.citation.volume1

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
file.pdf
Size:
214.78 KB
Format:
Adobe Portable Document Format
Download

Collections

Araştırma Çıktıları